Want to join the conversation?
Chip equipment maker $LRCX reported a lower 3Q16 profit, hurt by higher costs. The company reported quarterly earnings of $263.84MM, or $1.47 per share, down from $288.68MM, or $1.66 per share a year ago. Revenue rose to $1.63Bil from $1.60Bil a year ago. Expenses increased to $400.25MM from $386.94MM.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?